TERC and Alzheimer disease: For example, one study utilised a cross between the APP23 transgenic mouse model of AD and the Telomerase RNA component (Terc) knockout model of telomere shortening (G3Terc−/−APP23+) to investigate AD pathology on the background of shortened telomeres (Rolyan et al. 2011).